TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2015: $18.21M2016: $12.06M2017: $8.98M2018: $9.41M2019: $14.23M2020: $12.82M2021: $83.65M2022: $51.73M2023: $39.00M2024: $36.21M2025: $69.24M$69.24M
2015Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$69.24M+91.2%
2024$36.21M-7.2%
2023$39.00M-24.6%
2022$51.73M-38.2%
2021$83.65M+552.4%
2020$12.82M-9.9%
2019$14.23M+51.2%
2018$9.41M+4.9%
2017$8.98M-25.6%
2016$12.06M-33.8%
2015$18.21M—